CoChat

Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT)

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

AIMS/HYPOTHESIS: Insoluble cereal fibres have been shown in large prospective cohort studies to be highly effective in preventing type 2 diabetes, but there is a lack of interventional data. Our 2 year randomised double-blind prospective intervention study compared the effect of an insoluble oat fibre extract with that of placebo on glucose metabolism and incidence of diabetes. METHODS: A total of 180 participants with impaired glucose tolerance underwent a modified version of the 1 year lifestyle training programme PREvention of DIAbetes Self-management (PREDIAS) and were randomised to receive a fibre supplement (n = 89; 7.5 g of insoluble fibre per serving) or placebo (n = 91; 0.8 g of insoluble fibre per serving) twice daily for 2 years. Eligible participants were men and women, were at least 18 years old and did not report corticosteroid or other intensive anti-inflammatory treatment, fibre intolerance or any of the following disorders: overt diabetes, chronic or malignant disease, or severe cardiopulmonary, endocrine, psychiatric, gastrointestinal, autoimmune or eating disorder. Participants were recruited at two clinical wards in Berlin and Nuthetal. The allocation was blinded to participants and study caregivers (physicians, dietitians, study nurses). Randomisation was conducted by non-clinical staff, providing neutrally numbered supplement tins. Both supplements were similar in their visual, olfactory and gustatory appearance. Intention-to-treat analysis was applied to all individuals. RESULTS: level was significantly different between the two groups (-0.2 ± 4.6 mmol/mol [-0.0 ± 0.0%; not significant] vs +1.2 ± 5.2 mmol/mol [+0.1 ± 0.0%; not significant]; total difference 1.4 ± 0.7 mmol/mol [0.1 + 0.0%]); p = 0.018); insulin sensitivity and hepatic insulin clearance increased in both groups. After 2 years, improved insulin sensitivity was still present in both groups, although the effect size had diminished. Separate analysis of the sexes revealed a significantly greater reduction in 2 h glucose levels for women in the fibre group (-0.88 ± 1.59 mmol/l [p ≤ 0.001] vs -0.22 ± 1.52 mmol/l [p = 0.311]; total difference 0.67 ± 0.31 mmol/l; p = 0.015). Levels of fasting glucose, adipokines and inflammatory markers remained unchanged in the two groups. Significantly increased fibre intake was restricted to the fibre group, despite dietary counselling for both groups. No severe side effects occurred. CONCLUSIONS/INTERPRETATION: We cannot currently provide strong evidence for a beneficial effect of insoluble cereal fibre on glycaemic metabolism, although further studies may support minor effects of fibre supplementation in reducing glucose levels, insulin resistance and the incidence of type 2 diabetes. TRIAL REGISTRATION: clinicaltrials.gov NCT01681173 Funding: German Diabetes Foundation (grant no. 232/11/08).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-018-4582-6

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Glycaemic control after 1 year of intervention (placebo group, n = 66; fibre group, n = 64). ( a ) Fasting glucose; ( b ) 2 h glucose; ( c ) AUCGlucose; ( d ) fasting insulin sensitivity (HOMA-IR); ( e ) dynamic insulin sensitivity (SICederholm ); ( f ) HICC-peptide. White bars, placebo at
Fig. 1 Glycaemic control after 1 year of intervention (placebo group, n = 66; fibre group, n = 64). ( a ) Fasting glucose; ( b ) 2 h glucose; ( c ) AUCGlucose; ( d ) fasting insulin sensitivity (HOMA-IR); ( e ) dynamic insulin sensitivity (SICederholm ); ( f ) HICC-peptide. White bars, placebo atCC-BY · From the PDF
Fig. 2 Glycaemic control in women after 1 year of intervention (placebo group, n = 34; fibre group, n = 47). ( a ) Fasting glucose; ( b ) 2 h glucose; ( c ) AUCGlucose; ( d ) fasting insulin sensitivity (HOMA-IR); ( e ) dynamic insulin sensitivity (SICederholm); ( f ) HICC-peptide. White bars,
Fig. 2 Glycaemic control in women after 1 year of intervention (placebo group, n = 34; fibre group, n = 47). ( a ) Fasting glucose; ( b ) 2 h glucose; ( c ) AUCGlucose; ( d ) fasting insulin sensitivity (HOMA-IR); ( e ) dynamic insulin sensitivity (SICederholm); ( f ) HICC-peptide. White bars,CC-BY · From the PDF
Fig. 3 Mean dietary fibre intake without ( a ) and with ( b ) supplementation. White bars, placebo at baseline; light grey bars, placebo after 1 year of intervention; dark grey bars, fibre at baseline; black bars, fibre after 1 year of intervention. Data are mean ± SD. Significant change within the group: *** p ≤ 0.001; significant change between groups: ††† p ≤ 0.001
Fig. 3 Mean dietary fibre intake without ( a ) and with ( b ) supplementation. White bars, placebo at baseline; light grey bars, placebo after 1 year of intervention; dark grey bars, fibre at baseline; black bars, fibre after 1 year of intervention. Data are mean ± SD. Significant change within the group: *** p ≤ 0.001; significant change between groups: ††† p ≤ 0.001CC-BY · From the PDF
Table 2 Changes in dietary habits during the first year of the intervention
Table 2 Changes in dietary habits during the first year of the interventionCC-BY · From the PDF
Fig. 4 Glycaemic control after 2 years of intervention (placebo group, n = 54, fibre group, n = 52). ( a ) Fasting glucose; ( b ) 2 h glucose; ( c ) AUCGlucose; ( d ) fasting insulin sensitivity (HOMA-IR); ( e ) dynamic insulin sensitivity (SICederholm ); ( f ) HICC-peptide. White bars, placebo at
Fig. 4 Glycaemic control after 2 years of intervention (placebo group, n = 54, fibre group, n = 52). ( a ) Fasting glucose; ( b ) 2 h glucose; ( c ) AUCGlucose; ( d ) fasting insulin sensitivity (HOMA-IR); ( e ) dynamic insulin sensitivity (SICederholm ); ( f ) HICC-peptide. White bars, placebo atCC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. Brombach C, Wagner U, Eisinger-Watzl M, Heyer A (2006) Nationale Verzehrsstudie II. Ernährungs-Umschau 53:4–9 document in German

Cited by

See all 63

Metadata

Authors
Honsek, C., Kabisch, S., Kemper, M., Gerbracht, C., Arafat, A. M., Birkenfeld, A. L., Dambeck, U., Osterhoff, M. A., Weickert, M. O., & Pfeiffer, A. F. H.
Affiliations
  • German Institute of Human Nutrition (DE)
  • German Center for Diabetes Research (DE)
  • University Hospital Coventry (GB)
Corresponding author
  • Kabisch, Stefan
  • Weickert, Martin O.
Venue
Diabetologia
Published
2018-02-28
Volume
61
Issue
6
Pages
1295-1305
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2792266948
Cited by
63
References
31
Citations by year
2026: 3 · 2025: 8 · 2024: 11 · 2023: 8 · 2022: 11 · 2021: 8 · 2020: 5 · 2019: 5 · 2018: 4
FWCI
4.56
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Diabetologia (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
  • Site cant be reached (submittedVersion, cc-by)
Funders
German Diabetes Foundation (Grant No. 232/11/08; given to AFHP)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
insoluble dietary fiber, type 2 diabetes prevention, impaired glucose tolerance, glucose metabolism, insulin sensitivity, hepatic insulin clearance, HOMA-IR, sex differences, HbA1c, fasting insulin
MeSH terms
Aged, Diabetes Mellitus, Type 2, Diet, Dietary Fiber, Double-Blind Method, Female, Glucose, Glucose Tolerance Test, Humans, Male, Middle Aged, Prospective Studies, Self Care, Incidence, Caregivers, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT). https://app.cochat.ai/papers/10.1007/s00125-018-4582-6
The paper
Honsek, C., Kabisch, S., Kemper, M., Gerbracht, C., Arafat, A. M., Birkenfeld, A. L., Dambeck, U., Osterhoff, M. A., Weickert, M. O., & Pfeiffer, A. F. H. (2018). Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT). Diabetologia. https://doi.org/10.1007/s00125-018-4582-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.